On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...